It usually occurs alongside nausea and vomiting, particularly when treatment begins or dosage is increased
La fatiga o cansancio es un efecto adverso reportado por algunos pacientes que inician tratamiento con agonistas del receptor del pptido similar al glucagn tipo 1 (GLP-1), como semaglutida (Ozempic, Wegovy), dulaglutida (Trulicity) y liraglutida (Victoza, Saxenda)
37 Small molecule GLP-1RAs are chemically synthesized, and compared to protein-based drugs, they generally have smaller molecular sizes
The information provided in this article is for educational purposes only and should not be construed as medical advice
Will side effects be different
Patients need clear explanations about how these agents work, expected benefits, potential side effects, and the importance of adherence